Elucidating the underlying mechanisms for the differential response to sodium channel blocker antiarrhythmic drugs in obese patients with atrial fibrillation

Back

ESC Premium Access

Elucidating the underlying mechanisms for the differential response to sodium channel blocker antiarrhythmic drugs in obese patients with atrial fibrillation

Session: Cardiovascular drug therapy in special populations

Topic: Antiarrhythmic Pharmacotherapy

Speaker: Doctor M. Mccauley (Chicago, US)

Event: ESC Congress 2018

Congress Presentation

About the speaker

Doctor Mark Mccauley

University of Illinois at Chicago, Chicago (United States of America)

0 follower

7 more presentations in this session

Riociguat in transthyretin cardiac amyloidosis-data from a named patient use program in austria

Speaker: Doctor F. Duca (Vienna, AT)

Access

Abstract

The monocentric, double-blind, placebo-controlled research of sildenafil impact in pediatric patients with secondary pulmonary hypertension.

Speaker: Associate Professor I. Palii (Chisinau, MD)

Obesity paradox outcomes after acute myocardial infarction in Japanese is due to optimal medical therapy in overweight patients

Speaker: Assistant Professor K. Sakamoto (Kumamoto, JP)

The impact of additional mineralocorticoid receptor antagonist on guideline-recommended medical therapy in acute heart failure patients with ischemic heart disease.

Speaker: Doctor T. Abe (Saitama, JP)

Polymorphism RS776746 in the gene of CYP3A5 as a possible predictor of clinical efficiency of bisoprolol in patients transplanted with acute coronary syndrome

Speaker: Doctor V. Shumkov (Saint Petersburg, RU)

Access the full session

Cardiovascular drug therapy in special populations

Speakers: Doctor M. Mccauley, Doctor F. Duca, Associate Professor I. Palii, Assistant Professor K. Sakamoto, Doctor T. Abe...

Access

About the event

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress

Elucidating the underlying mechanisms for the differential response to sodium channel blocker antiarrhythmic drugs in obese patients with atrial fibrillation

About the speaker

Doctor Mark Mccauley

7 more presentations in this session

Riociguat in transthyretin cardiac amyloidosis-data from a named patient use program in austria

The monocentric, double-blind, placebo-controlled research of sildenafil impact in pediatric patients with secondary pulmonary hypertension.

Obesity paradox outcomes after acute myocardial infarction in Japanese is due to optimal medical therapy in overweight patients

The impact of additional mineralocorticoid receptor antagonist on guideline-recommended medical therapy in acute heart failure patients with ischemic heart disease.

Polymorphism RS776746 in the gene of CYP3A5 as a possible predictor of clinical efficiency of bisoprolol in patients transplanted with acute coronary syndrome

Access the full session

Cardiovascular drug therapy in special populations

About the event

ESC Congress 2018

ESC 365 is supported by